CLINICAL_TRIALS
trial_result
· 2017-03-28
Clinical Trial Update: To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets [Phase 1]
Summary
A Phase 1 study by Sandoz evaluating the relative bioavailability of loratadine 10 mg tablets has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sandoz | Conditions: Allergy | Phase 1 | Status: COMPLETED